Scientists discover protein that helps trigger allergic asthma
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists have discovered a blood clotting protein they believe contributes towards allergic asthma, a finding that could help develop more targeted treatments in the future.
Allergic asthma is often marked by symptoms like difficulty drawing breath, wheezing and coughing, and can be trigged by different factors in the environment such as dust, mold or animals.
Co-author David Corry explained that "asthma is part of a battle that takes place as the immune system marshals its forces to fight off an invading organism-or what mimics such invaders."
This "fight" significantly affects the human airway and lungs, generating an often violent and potentially deadly reaction - asthma.
Researchers at the Baylor College of Medicine in Houston induced allergic reactions in mice by exposing the animals the proteinases found in mold.
These proteinases break down a blood-clotting protein called fibrinogen. The resulting pieces of fibrinogen bind to and activate the TLR4 pathway.
Dr. Corry found the same fibrinogen fragments that are part of the blood clotting process can cause clotting that creates a barrier to breathing and inflammation, triggering allergic asthma.
But when the team prevented this fibrinogen breakdown, the mice had a reduced reaction to mold spores.
This also occurred in mice lacking TLR4, suggesting that both proteins are part of a protective biological chain of events in some people, but not others, according to Science News.
"We suspect asthma is a protective response against fungi in many people", Dr Corry said. But in others, “it’s an aberrant response induced by extreme sensitivity to the proteinases.”
Stephanie Eisenbarth, a physician and immunologist at the Yale School of Medicine told Science News that these findings "made perfect sense".
“Fibrinogen may be a canary in a coal mine — acting as a detector of something pathogenic that may not be detected by classic mechanisms,” she said.
Dr Corry argues the findings give a further insight into the TLR4 pathway, but the specifics of allergy and immunity are still being investigated by scientists.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments